Compassionate Use of Sodium Stibogluconate (Pentostam) for Cutaneous and Mucocutaneous New World Leishmaniasis

N/ANo Longer AvailableNCT00508963

University of California, San Francisco

Overview

Patients with biopsy proven new world cutaneous or mucocutaneous leishmaniasis will be treated with sodium stibogluconate (Pentostam).

Study Type

EXPANDED_ACCESS

20 mg/kg IV every day for 20 or 28 days

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Biopsy proven new world cutaneous or mucocutaneous leishmania Exclusion Criteria: * Prolonged QT * Liver disease * Pancreatitis

University of CA at San Francisco Hospitals and Clinics

San Francisco, California, United States

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.